Ann: HepaFat-AI Receives TGA Approval, page-21

Effective for you and I the investor IMO of course.
The business model is awesome being completely internet based .
Customers world wide.
Moving effectively into the AI world with genuine tests with partners a plenty.
The background tests they have been working on for years along side and with current in focus tests with AI partners is diverse and many.
Liver fibrosis test relating to Hepatitis C is a baby they have been perfecting for many years and will surge their earnings and profile.
Development in MRI scanners are all to their benefit.
Like I said , FDAs give the pump but the underlying business model is profitable and growing.
If your in a hurry there are other places of course to go.